Bendroflumethiazide 2.5mg tablets

Država: Velika Britanija

Jezik: engleski

Izvor: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktivni sastojci:

Bendroflumethiazide

Dostupno od:

Wockhardt UK Ltd

ATC koda:

C03AA01

INN (International ime):

Bendroflumethiazide

Doziranje:

2.5mg

Farmaceutski oblik:

Oral tablet

Administracija rute:

Oral

Razred:

No Controlled Drug Status

Tip recepta:

Valid as a prescribable product

Proizvod sažetak:

BNF: 02020100; GTIN: 5012727903606

Uputa o lijeku

CHANGE CONTROL : Version changes due to change in:
Size/Layout Regulatory Non-Regulatory
Changes in detail:
• New regulatory text
• Removed pre-printed L.I.No. from front page 1/2
_1st fold_
_(26.25mm)_
_2nd fold_
_(26.25mm)_
_3rd fold_
_(26.25mm)_
_4th fold_
_(26.25mm)_
_5th fold_
_(26.25mm)_
_6th fold_
_(26.25mm)_
_7th fold_
_(26.25mm)_
_8th fold_
_(26.25mm)_
_9th fold_
_(26.25mm)_
_10th fold_
_(26.25mm)_
_11th fold_
_(26.25mm)_
_12th fold_
_(26.25mm)_
_13th fold_
_(26.25mm)_
_14th fold_
_(26.25mm)_
_15th fold_
_(26.25mm)_
_16th fold_
_(26.25mm)_
READ ALL OF THIS LEAFLET CAREFULLY BEFORE
YOU START TAKING THIS MEDICINE
BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
-
Keep this leaflet. You may need to
read it again.
-
If you have any further questions,
please ask your doctor or pharmacist.
-
This medicine has been prescribed for
you only. Do not pass it on to others. It
may harm them, even if their signs of
illness are the same as yours.
-
If you get any side effects, talk to your
doctor or pharmacist. This includes
any possible side effects not listed in
this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1. What Bendroflumethiazide Tablets are
and what they are used for
2. What you need to know before you
take Bendroflumethiazide Tablets
3. How to take Bendroflumethiazide
Tablets
4. Possible side effects
5. How to store Bendroflumethiazide
Tablets
6. Contents of the pack and other
information
1. WHAT BENDROFLUMETHIAZIDE TABLETS
ARE AND WHAT THEY ARE USED FOR
The name of your medicine is
Bendroflumethiazide Tablets. The active
ingredient in your medicine is
bendroflumethiazide.
Bendroflumethiazide Tablets belong to a
group of medicines called diuretics
(water tablets) which increase the
amount of urine you produce.
Bendroflumethiazide Tablets are used to
treat high blood pressure (hypertension)
and fluid retention (oedema) associated
with kidney, liver or heart problems, and
pre-menstrual syndrome.
2. WHAT YOU NEED TO KNOW BEFORE YOU
TAKE BENDROFLUMETHIAZIDE TABLETS
DO NOT TAKE BENDROFLUMETHIAZIDE
TABL

Svojstava lijeka

OBJECT 1
BENDROFLUMETHIAZIDE 2.5MG TABLETS
Summary of Product Characteristics Updated 20-Feb-2019 | Wockhardt UK
Ltd
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Bendroflumethiazide 2.5mg Tablets
2. Qualitative and quantitative composition
Bendroflumethiazide 2.5mg
For the full list of excipients, see section 6.1
Each tablet contains 49.85mg of lactose.
3. Pharmaceutical form
White, circular flat faced tablets with bevelled edges, having a CP
logo on one face and B 2.5 separated by a
breakline on the reverse.
4. Clinical particulars
4.1 Therapeutic indications
Bendroflumethiazide is indicated for:
Cases where the reduction of fluid retention by diuresis is required;
oedema of cardiac, renal or hepatic origin
and iatrogenic oedema.
Bendroflumethiazide produces a moderate but usefully prolonged fall of
blood pressure in hypertensive
patients. It may be used as the sole antihypertensive agent or as an
adjunct to other drugs whose action it
potentiates. In non-oedematous